Table of Contents

September 2017, Volume 24, Number 9

Editorial

    • Karen Crasta and
    • Ritu Aneja

    50 years on … the discovery of tubulin continues to advance cancer treatment

    Endocr Relat Cancer 24 (9) E3-E5, doi:10.1530/ERC-17-0273

Thematic Review

    • Rachana Rao Battaje and
    • Dulal Panda

    Lessons from bacterial homolog of tubulin, FtsZ for microtubule dynamics

    Endocr Relat Cancer 24 (9) T1-T21, doi:10.1530/ERC-17-0118 first published on 20 June 2017
    • Sarah E McClelland

    Role of chromosomal instability in cancer progression

    Endocr Relat Cancer 24 (9) T23-T31, doi:10.1530/ERC-17-0187 first published on 10 July 2017
    • Sock Hoai Chan and
    • Joanne Ngeow

    Germline mutation contribution to chromosomal instability

    Endocr Relat Cancer 24 (9) T33-T46, doi:10.1530/ERC-17-0062
    • Angela Ogden,
    • Padmashree C G Rida,
    • and Ritu Aneja

    Centrosome amplification: a suspect in breast cancer and racial disparities

    Endocr Relat Cancer 24 (9) T47-T64, doi:10.1530/ERC-17-0072 first published on 17 May 2017
    • Shivangi Agarwal and
    • Dileep Varma

    Targeting mitotic pathways for endocrine-related cancer therapeutics

    Endocr Relat Cancer 24 (9) T65-T82, doi:10.1530/ERC-17-0080 first published on 14 June 2017
    • Jue Shi and
    • Timothy J Mitchison

    Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic

    Endocr Relat Cancer 24 (9) T83-T96, doi:10.1530/ERC-17-0003 first published on 1 March 2017
    • Bing Cheng and
    • Karen Crasta

    Consequences of mitotic slippage for antimicrotubule drug therapy

    Endocr Relat Cancer 24 (9) T97-T106, doi:10.1530/ERC-17-0147 first published on 6 July 2017
    • Roberta Visconti and
    • Domenico Grieco

    Fighting tubulin-targeting anticancer drug toxicity and resistance

    Endocr Relat Cancer 24 (9) T107-T117, doi:10.1530/ERC-17-0120

Commentary

    • Rodrigo Almeida Toledo

    New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas

    Endocr Relat Cancer 24 (9) C9-C19, doi:10.1530/ERC-16-0479 first published on 30 June 2017

Review

    • Annunziata Di Domenico,
    • Tabea Wiedmer,
    • Ilaria Marinoni,
    • and Aurel Perren

    Genetic and epigenetic drivers of neuroendocrine tumours (NET)

    Endocr Relat Cancer 24 (9) R315-R334, doi:10.1530/ERC-17-0012 first published on 14 July 2017
    • Takuma Uo,
    • Stephen R Plymate,
    • and Cynthia C Sprenger

    Allosteric alterations in the androgen receptor and activity in prostate cancer

    Endocr Relat Cancer 24 (9) R335-R348, doi:10.1530/ERC-17-0108

Research

    • W Imruetaicharoenchoke,
    • A Fletcher,
    • W Lu,
    • R J Watkins,
    • B Modasia,
    • V L Poole,
    • H R Nieto,
    • R J Thompson,
    • K Boelaert,
    • M L Read,
    • V E Smith,
    • and C J McCabe

    Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF

    Endocr Relat Cancer 24 (9) 459-474, doi:10.1530/ERC-16-0340 first published on 4 July 2017
    OPEN ACCESS ARTICLE
    • Hiroshi Imaoka,
    • Mitsuhito Sasaki,
    • Hideaki Takahashi,
    • Yusuke Hashimoto,
    • Izumi Ohno,
    • Shuichi Mitsunaga,
    • Kazuo Watanabe,
    • Kumiko Umemoto,
    • Gen Kimura,
    • Yuko Suzuki,
    • and Masafumi Ikeda

    Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms

    Endocr Relat Cancer 24 (9) 475-483, doi:10.1530/ERC-17-0197 first published on 6 July 2017
    • Vincenzo Marotta,
    • Concetta Sciammarella,
    • Maria Grazia Chiofalo,
    • Claudio Gambardella,
    • Claudio Bellevicine,
    • Marica Grasso,
    • Giovanni Conzo,
    • Giovanni Docimo,
    • Gerardo Botti,
    • Simona Losito,
    • Giancarlo Troncone,
    • Maurizio De Palma,
    • Laura Giacomelli,
    • Luciano Pezzullo,
    • Annamaria Colao,
    • and Antongiulio Faggiano

    Hashimoto’s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer

    Endocr Relat Cancer 24 (9) 485-493, doi:10.1530/ERC-17-0085 first published on 10 July 2017
    • Massimo Terzolo,
    • Giuseppe Reimondo,
    • Paola Berchialla,
    • Emanuele Ferrante,
    • Elena Malchiodi,
    • Laura De Marinis,
    • Rosario Pivonello,
    • Silvia Grottoli,
    • Marco Losa,
    • Salvatore Cannavo,
    • Diego Ferone,
    • Marcella Montini,
    • Marta Bondanelli,
    • Ernesto De Menis,
    • Chiara Martini,
    • Efisio Puxeddu,
    • Antonino Velardo,
    • Alessandro Peri,
    • Marco Faustini-Fustini,
    • Patrizia Tita,
    • Francesca Pigliaru,
    • Giulia Peraga,
    • Giorgio Borretta,
    • Carla Scaroni,
    • Nicoletta Bazzoni,
    • Antonio Bianchi,
    • Alessandro Berton,
    • Andreea Liliana Serban,
    • Roberto Baldelli,
    • Letizia Maria Fatti,
    • Annamaria Colao,
    • Maura Arosio,
    • and for the Italian Study Group of Acromegaly

    Acromegaly is associated with increased cancer risk: a survey in Italy

    Endocr Relat Cancer 24 (9) 495-504, doi:10.1530/ERC-16-0553 first published on 14 July 2017

Research Letter

    • Luis G Perez-Rivas,
    • Andrea Oßwald,
    • Thomas Knösel,
    • Kristin Lucia,
    • Christian Schaaf,
    • Michael Hristov,
    • Julia Fazel,
    • Thomas Kirchner,
    • Felix Beuschlein,
    • Martin Reincke,
    • and Marily Theodoropoulou

    Expression and mutational status of USP8 in tumors causing ectopic ACTH secretion syndrome

    Endocr Relat Cancer 24 (9) L73-L77, doi:10.1530/ERC-17-0054 first published on 14 July 2017
|

This Issue

September 2017; 24 (9)
  1. Editorial
  2. Thematic Review
  3. Commentary
  4. Review
  5. Research
  6. Research Letter

Find articles in this issue containing these words:

New Articles: issue in progress

  1. April 2018, 25 (4)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most